South San Francisco,
MyoKardia, Inc. is a private, early clinical-stage biopharmaceutical company located in South San Francisco, California. Our vision is to revolutionize the treatment of genetic heart disease. We bring together fundamental and...
Regulus Therapeutics, Inc.
Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is uniquely positioned to leverage a mature therapeutic platform that harnesses the...